Syndax Pharmaceuticals Inc (SNDX) presents a great opportunity, but the stock is slightly undervalued
While Syndax Pharmaceuticals Inc has underperformed by -2.86%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance,